an N-terminal ␤ barrel, a C-terminal ␤ grasp motif, and an ␣ helices-spanning center), considering their low se-S-221 00 Lund Sweden quence identity [4]. Crystal structures of superantigens in complex with 2 Active Biotech Research AB P.O. Box 724 MHC class II have shown that they either interact with the ␣ chain, as in SEB and TSST-1 [5, 6], or with the ␤ S-220 07 Lund Sweden chain, in a zinc-dependent manner, as in SEH and SPE-C [7, 8] of MHC class II. Both SEH and SPE-C coordinate a zinc ion in a similar manner, with one aspartate and one or two histidine residues. The zinc ion bridges His81 Summary on MHC class II, which is the third ligand (the fourth in the case of SPE-C). SEA coordinates zinc in a similar Although the biological properties of staphylococcal manner to SEH and SPE-C, using Asp227, His225, and enterotoxin A (SEA) have been well characterized, His187, and is believed to interact with His81 on MHC structural insights into the interaction between SEA class II in a similar manner, as well [7-9]. Alanine substiand major histocompatibilty complex (MHC) class II tution studies have shown that SEA is able to interact have only been obtained by modeling. Here, the crystal with either the ␣ chain or the ␤ chain of MHC class II structure of the D227A variant of SEA in complex with [10, 11]. SEA binds with its N-terminal domain, with low human MHC class II has been determined by X-ray affinity ‫01ف(‬ M), to the ␣ chain of MHC class II and crystallography. SEA D227A exclusively binds with its with its C-terminal domain, in a zinc-dependent manner, N-terminal domain to the ␣ chain of HLA-DR1. The with medium affinity ‫001ف(‬ nM), to the ␤ chain [10]. ability of one SEA molecule to crosslink two MHC mol-It is well established that superantigens, in general, ecules was modeled. It shows that this SEA molecule and SEA, in particular, may be used clinically. Most cannot interact with the T cell receptor (TCR) while a extensive studies have been performed in the field of second SEA molecule interacts with MHC. Because cancer therapy [12]. Because of its low systemic toxicity, of its relatively low toxicity, the D227A variant of SEA the SEA D227A variant is successfully used in clinical trials is used in tumor therapy. in the treatment of lung cancer patients [13]
of SEA has been suggested to provide one of the coordinates to the zinc ion [9]. This residue, Ser1, is seen in Alanine substitution studies have shown that SEA has two binding sites for human MHC class II, one N-terminal the DR1-SEA D227A complex structure and is positioned in such a way that it could coordinate a zinc ion. However, site and one C-terminal zinc-dependent site [10, 11]. We have chosen to crystallize a variant of SEA in which residues 3-6 in the N-terminal region of SEA D227A are not seen, possibly due to disordering of the protein. the C-terminal zinc-dependent site is believed to be abrogated. In this way, we have been able to capture A second zinc site, which is situated between the two domains of the protein, has been observed in SEA by the complex in which SEA uses its low affinity site when binding to HLA-DR1. The major interactions between X-ray crystallography [14] . Thermal denaturation also shows that zinc ions can stabilize the structure of SEA D227A and HLA-DR1 are between the N-terminal ␤ barrel of SEA D227A and the ␣ chain of HLA-DR1. The super-SEA D227A [15]. However, no such zinc site is detected in the DR1-SEA D227A structure, although the crystallization antigen binds to one side of HLA-DR1, outside the peptide binding groove, and does not contact the peptide was performed in the presence of 1 mM ZnCl 2 . This second zinc binding site may therefore only be relevant (Figures 1 and 2 ; Table 1 ).
The overall structure of SEA D227A in complex with HLA-at higher concentrations of zinc. A similar zinc site was also observed in the crystal structure of SEC 2 , and it DR1 has minor conformational changes compared with the uncomplexed structure of SEA [9]. The major differ-has been suggested to be important for SEC 1 when interacting with MHC class II [16, 17]. Two of these ence is in the C-terminal domain in the zinc binding area, where no electron density for a zinc ion is seen in the corresponding and putative zinc coordinating ligands in SEA, His114 and Glu39, have previously been substi-3.2 Å 2F o Ϫ F c map. This is expected, since Asp227 in SEA is known to be one of the three zinc ligands, ac-tuted to investigate the consequence for MHC class II binding [10]. Neither the MHC class II binding nor the cording to mutagenesis studies [10]. Hence, when Asp227 is substituted to an alanine, the SEA molecules ability to mediate T cell cytotoxicity was affected, and, an interaction (Figure 1 ).
Discussion The Interface between SEA D227A and HLA-DR1
The total accessible area in the complex is 29,896 Å 2 , calculated with GRASP [19] , with an interface burying In this study, the crystal structure of SEA D227A in complex with HLA-DR1 was determined at 3.2 Å resolution. 554 Å 2 and 567 Å 2 of the HLA-DR1 and SEA D227A solventaccessible surfaces, respectively [20] . The interface be-SEA D227A binds to the ␣ chain of HLA-DR1 and does not contact the presented Ha-peptide. The D227A substitu-tween SEA D227A and HLA-DR1 consists of a ridge of nonpolar residues (Phe47, Leu48, and His50) situated on tion of SEA prevents the superantigen from interacting with the ␤ chain of HLA-DR1 through the zinc-dependent the loop between the ␤1 and ␤2 strands of SEA D227A , which protrudes their side chains into the cavity be-site on the C-terminal domain. tween the ␣1 helix and the ␤ sheet that creates the peptide binding groove of HLA-DR1. The amino acids Comparison with SEB The overall structure of the DR1-SEA D227A complex mim-creating the ridge, in particular, Phe47, interact with several nonpolar amino acids (Leu60, Ile63, and Ala64) ics the binding between SEB and HLA-DR1, in general [5, 22] . However, the contacting region between SEA D227A located on the ␣1 helix of HLA-DR1 as well as with Lys39 and Met36, situated on the loop between the ␤3 and ␤4 and HLA-DR1 is only around 70% of the contacting region of DR1-SEB (burying 788 Å 2 and 764 Å 2 of the strands on the ␣ chain of HLA-DR1. In addition, Asp70 of SEA D227A makes a salt bridge with Lys39. A hydrogen HLA-DR1 and SEB solvent-accessible surfaces, respectively). The major difference between the two superanti-bond is seen between His50 and Asp70, both on SEA D227A , which possibly stabilizes the interface by di-gen-HLA-DR1 complexes is that the SEA D227A is partially rotated away from the HLA-DR1 molecule compared recting Asp70 to Lys39 on HLA-DR1, hence facilitating the salt bridge formation. Two hydrogen bonds are likely with SEB ( Figure 2 ). The rotation is mainly due to movement of the disulphide loop caused by a replacement to be formed between Gln46 and Gln95 on SEA D227A and Gln18 and Gln57 on the ␣ chain of HLA-DR1, respec-of Tyr94 in SEB, which stabilizes the DR1-SEB complex, to the corresponding Ala97 in SEA D227A . In addition, Ser96 tively. The interaction between Gln46 and Gln18 is close to the hydrophobic interacting area between SEA D227A in SEB, also situated on the disulphide loop, contacts HLA-DR1, as well. In the interface of DR1-SEB, there are and HLA-DR1 (described above), while the interaction between Gln95 (SEA D227A ) and Gln57 (HLA-DR1) is situ-seven hydrogen bonds between the molecules, while, in the DR1-SEA D227A complex, there are only two hydrogen ated between the disulphide loop of SEA D227A and the ␣1 domain of the ␣ helix of HLA-DR1 ( Figure 3A) . The bonds. For instance, in the DR1-SEB structure, two hydrogen bonds are formed from Tyr89 and Tyr115 on importance of Phe47 on SEA and Lys39 and Gln18 on HLA-DR1 for complex formation as well as for T cell SEB to Lys39 of HLA-DR1 ( Figure 3B ). These are in close proximity to the salt bridge between Glu67 of SEB and using its N-terminal and C-terminal domains. This is in agreement with previous results demonstrating the the same lysine. In the DR1-SEA D227A structure, a similar salt bridge is formed between Asp70 of SEA D227A and importance of simultaneous ligation of both the ␣ chain and the ␤ chain of two different MHC class II molecules Lys39 of HLA-DR1, but the two corresponding residues (Tyr92 and Tyr108), although structurally aligned with for optimal T cell response by SED and SEE in cellbased studies [33]. the two tyrosines in SEB, are too far from HLA-DR1 to be able to form hydrogen bonds. This is due to a small conformational change of the side chain of Lys39 (2 Å T Cell Activation movement of the nitrogen; Figure 3 ) as well as a larger Substitution studies have been performed with SEA to overall distance between the SEA D227A and the HLA-DR1 explain the consequence of the two MHC class II binding molecules than in the DR1-SEB complex. The comparasites for optimal T cell activation. Eliminating the lowbly small contact region for the DR1-SEA D227A complex affinity class II binding site had a stronger influence on is correlated to the ability for residues on SEA D227A to the V␤ profile than did the removal of the medium-affinity make van der Waals contacts with HLA-DR1. Hence, this zinc-dependent site 
for one MHC class II molecule to simultane-MHC class II molecules, utilizing both the low-and medium-affinity sites, results in a high-affinity interaction
ously interact with TCR and with two SEA molecules. The V␣ chain of TCR and the second SEA molecule that with MHC class II. The DR1-SEA D227A structure demonstrates that SEA is able to crosslink two MHC class II interacts with the ␤ chain of MHC class II will totally overlap ( Figure 4B) DR1-SEH (1HXY) [7] , superimposing the site to induce an optimal T cell response (SEA 1 -MHC 2 ). As a consequence of crosslinking, there must be more HLA-DR1 molecules to model the medium-affinity site between SEA and HLA-DR1 (Figure 4) . Sequence align-MHC class II molecules present than SEA on the cell surface, which agrees well with data where less than ment with Clustal W [32] shows that, in addition to SEA, there are three other bacterial superantigens, SED, SEE, 0.3 % of the cell surface MHC class II needs to be occupied by SEA to generate an optimal T cell response and SEJ, that may crosslink MHC class II molecules by 
. However, trimeric complexes (SEA 2 -molecules because the C-terminal domain is directed away from the bound HLA-DR1 and is completely free MHC 1 ) have been seen in solution [39], and these complexes might appear on the cell's surface, but the first to interact with another MHC class II molecule with no steric hindrance. The ability of SEA to use both sites SEA molecule will not be able to interact with the TCR because of the overlap between the second SEA and for MHC class II binding has earlier been shown to be important for optimal T cell activation and cytokine in-TCR (Figure 4). Consequently, it is not possible for SEA and MHC class II to oligomerize and create chains of duction [27-29]. The interaction between the C-terminal domain of SEA and HLA-DR1 is suggested to be very complexes on the cell surface for an optimal T cell activation. similar to the interaction between SEH and HLA-DR1. This is supported by the fact that both superantigens The model for crosslinking two MHC molecules by SEA suggests a mechanism where the medium-affinity have a zinc-dependent interaction with the ␤ chain of HLA-DR1 as well as an interaction with the antigenic zinc-dependent site is the first and most important interaction between SEA and MHC class II. When that bind-peptide [7, 11, 30, 31]. A model of SEA crosslinking two MHC class II molecules was created by performing ing has been established, SEA binds a second MHC class II molecule on the cell surface using its low-affinity structural alignment between the complexes DR1-SEA D227A and

[40]. However, SEA may be presented to TCR, although low-affinity sites interact with MHC class II molecules [28]. Hence, the zinc-dependent site is important for SEA less optimally, using only its medium-affinity site. In this case there will be no direct interaction between TCR to find the MHC class II molecules on the cell surface of APCs, while the low-affinity site is more important for and MHC, according to the quaternary complex (MHC 2 -SEA 1 -TCR 1 ) model. It has been demonstrated that T cells activating a broad V␤ repertoire of T cells. activated when SEA is presented only by its mediumaffinity site are also activated by SEA in the absence of
Tumor-Targeted Superantigens Bacterial toxins have been known since the beginning MHC class II molecules [41] . This concludes that, when SEA is suboptimally presented by MHC, no interaction of the twentieth century to have antitumor effects [42] . An approach of superantigen-based tumor therapy has between MHC and TCR will occur. The suboptimal presentation of SEA will lead to stimulation of a more selec-been developed where a superantigen is fused to fragments of tumor-reactive monoclonal antibodies [43] . In tive TCR V␤ repertoire than when both the medium-and 2.5 g of (NH 4 ) 2 cules is essential for SEA to be able to activate a large A data set was collected at beamline I711 at the MAX laboratory population of T cells and, hence, become one of the in Lund, Sweden, with a MarCCD detector. The data set was evaluated in MOSFLM [48] and scaled with the CCP4 suite of programs most potent superantigens. Crosslinking also stimulates [49] . Statistics on data collection and quality are presented in antigen-presenting cells to secrete inflammatory cyto- Table 1. kines. In addition, the low-affinity site is here shown to be important for the proper presentation of SEA to TCR, pared with wild-type SEA.
More than 97% of all residues are in the most favored or allowed regions in the Ramachandran plot, and only 0.7% are in disallowed regions, according to the PROCHECK program [53] . Details of the Experimental Procedures structure are given in Table 1 .
Cloning, Protein Overexpression, and Purification
Recombinant SEA was expressed in the Escherichia coli K12 strain
